Որոնման արդյունքները - Cierra N. Sharp
- Ցուցադրվում են 1 - 5 արդյունքները 5
-
1
-
2
-
3
C57BL/6 mice require a higher dose of cisplatin to induce renal fibrosis and CCL2 correlates with cisplatin-induced kidney injury Sophia M. Sears, Cierra N. Sharp, Austin Krueger, Gabrielle B. Oropilla, Douglas Saforo, Mark A. Doll, Judit Megyesi, Levi J. Beverly, Leah J. Siskind
Հրապարակվել է 2020Artigo -
4
Repeated administration of low-dose cisplatin in mice induces fibrosis Cierra N. Sharp, Mark A. Doll, Tess V. Dupre, Parag P. Shah, Subathra Marimuthu, Deanna Siow, Gavin E. Arteel, Judit Megyesi, Levi J. Beverly, Leah J. Siskind
Հրապարակվել է 2016Artigo -
5
Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury Tess V. Dupre, Mark A. Doll, Parag P. Shah, Cierra N. Sharp, Deanna Siow, Judit Megyesi, James A. Shayman, Alicja Bielawska, Jacek Bielawski, Levi J. Beverly, María José Hernandez‐Corbacho, Christopher J. Clarke, Ashley J. Snider, Rick G. Schnellmann, Lina M. Obeid, Yusuf A. Hannun, Leah J. Siskind
Հրապարակվել է 2017Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Chemotherapy
Cisplatin
Internal medicine
Medicine
Pharmacology
Kidney
Acute kidney injury
Fibrosis
Kidney disease
Dosing
Glomerulosclerosis
Nephrotoxicity
Pathology
Proteinuria
Regimen
Administration (probate law)
Apoptosis
Biochemistry
Biology
Cancer research
Ceramide
Chemistry
Endocrinology
Enzyme
Immunology
Inflammation
Intensive care medicine
Lactosylceramide
Law
Oncology